Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Portnoy

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Antimicrobial Agents and Chemotherapy|April 1, 1984
Rosoxacin in the therapy of uncomplicated gonorrheaB Romanowski, T W Austin, F L Pattison, et al.
Critical Care Medicine|April 9, 2004
Risk factors for mortality in 137 pediatric cardiac intensive care unit patients managed with extracorporeal membrane oxygenationMarilyn C Morris, Richard F Ittenbach, Rodolfo I Godinez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2016
Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progressionR Obermannová, E Van Cutsem, T Yoshino, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Antimicrobial Agents and Chemotherapy|April 1, 1984
Rosoxacin in the therapy of uncomplicated gonorrheaB Romanowski, T W Austin, F L Pattison, et al.
Critical Care Medicine|April 9, 2004
Risk factors for mortality in 137 pediatric cardiac intensive care unit patients managed with extracorporeal membrane oxygenationMarilyn C Morris, Richard F Ittenbach, Rodolfo I Godinez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2016
Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progressionR Obermannová, E Van Cutsem, T Yoshino, et al.
Pageof 4